Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-09-29
2000-12-05
Housel, James C.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 71, G01N 33573
Patent
active
061565253
ABSTRACT:
A method of judging the eradication of H. pylori to judge whether the sample is positive or negative through a quick and easily operation is provided. A PG I value and a PG II value in the body fluids (e.g., in the blood) of an H. pylori positive patient are measured before the H. pylori eradicating treatment and after the passage of a period in which a substantially significant result occurs from the eradicating treatment, a PG I/PG II ratio in the body fluids (e.g., in the blood) is found, a rate of change in the PG I/PG II ratio in the body fluids (e.g., in the blood) is found before the H. pylori eradicating treatment and after the passage of the period in which a substantially significant result occurs from the eradicating treatment, and the change in the PG I/PG II ratio is used as a marker to indicate that H. pylori is eradicated.
REFERENCES:
patent: 4830010 (1989-05-01), Marshall
Hunter et al., "Serum Pepsinogens as Markers of Response to Therapy Helicobacter pylori Gastritis", Digestive Diseases and Sciences, vol. 38, No. 11, pp. 2081-2086, Nov. 1993.
Asaka et al., "The Role of Helicobacter pylori in Peptic Ulcer Disease", Gastroenterol Jpn., vol. 28, Suppl. 5, pp. 163-167, 1993.
Chittajallu et al., "Effect of Helicobacter pylori on Serum Pepsinogen I and Plasma Gastrin in Duodenal Ulcer Patients", Scand J. Gastroenterol, vol. 27, pp. 20-24, 1992.
Rauws et al., "Campylobacter pyloridis-Associated Chronic Active Antral Gastritis", Gastroenterology, vol. 94, No. 1, pp. 33-49, 1988.
Ichinose et al., "Radioimmunoassay of Serum Group I and Group II Pepsinogens in Normal Controls and Patients with Various Disorders", Clinica Chimica Acta., vol. 126, pp. 183-191, 1982.
Samloff et al., "Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology", Gastroenterology, vol. 83, No. 1. pp. 204-209, Jul. 1982.
Fraser, A.G. et al, Aliment. Pharmacol. Ther., 1992, vol. 6(3), p. 389-94.
Plebani, M et al, Lancet, vol. 340, Jul. 4, 1992, pp. 51-52.
Karnes, W.E. et al, Gastroenter., 1991, vol. 101(1), p. 167-174.
Nakata, H. et al, J. Clin. Gastroenterol., 1995, vol. 20 (Sup. 2), p. 5118-20.
Chang, FY et al, Curr. Therap. Res., vol. 56(9), Sep. 1995, p. 887-893.
Asaka, M. et al, Gastroent, 1992, vol. 102(3), p. 760-766.
Biasco, G et al, J. Clin Patnol., Sep. 1993, vol. 46(9) p. 826-8.
Ivey, KJ, J. Gastrolentol. Hepatol., 1994, vol. 9 (Suppl 1), p. 5109-11.
Fukuda, H. et al, Jpn. J. Cancer. Res., vol. 86(1), p. 64-71, Jan. 1995.
Schlemper, R.J. et al, Gut, 1995, vol. 37(2), p. 199-204.
Parente, F. et al, Gut, 1995, vol. 37(2), p. 210-215.
Dotto, P et al, Aug. 1995, Curr. Therp. Res., vol. 56(8), p. 777-786.
Furuta, T. et al, J. Clin. Gast., 1995, vol. 20 (Suppl. 2), 5107-111.
Plebani, M, Crit. Rev. Clin. Lab. Sci, 1993, vol. 30(3), p. 273-328.
Wagner, S. et al, Am. J. Gastroent., vol. 89(8), 1994, p. 1211-8.
Kato, I. et al, Int'l, J. of Cancer, 1995, vol. 62(5) p. 512-18.
Ashorn, M et al, Scad. J. Gastroenterol., Mar. 1994, vol. 29(3) p. 203-8.
Pilotto, A et al, Jun. 1996, vol. 44(6), p. 665-670, JAGS.
Aoyama et al (Apr. 1995), Gastroenterol, vol. 108(4), PA 47.
De Bona et al, 1994, Am. J. Gastroenterol., vol. 89(8) p. 1369.
Dotto et al (Aug. 1995), Current Therapeutic Res. vol. 55(8), p. 777-786.
Ferrana et al (Apr. 1995), Gastroenterol, vol. 108(4), PA93.
Wagner et al, 1994, Am. J. of Gastroenterol., vol. 89(8), p. 1211-1218.
Westerveld, B.D. et al, Cancer, vol. 59, Mar. 1, 1987, p. 952-958.
Di Mario et al (Jul. 1995), Gut, vol. 37(Suppl. 1), A57.
Fukuda et al (Jan. 1995), Japanese J. Cancer. Res., vol. 86(1), p. 64-71.
Schlemper et al (1995), Gut, vol. 37(2), p. 199-204.
Vianello et al (1994), Am. J. Gastroenterol., vol. 89(8) p. 1390.
Kato, I. et al, Int. J. Cancer, vol. 62(5), p. 512-518, 1995.
I Michael Samloff et al, Gastroenterol., 1982, vol. 83, p. 204-9.
Plebani, M., Crit. Rev. Clin. Lab. Sci., 1993, vol. 30(3), p. 273-328.
Hunter et al, 1993, vol. 38(11), Dig. Dis. and Science, p. 2081-2086.
Housel James C.
Portner Ginny Allen
LandOfFree
Method for judging eradication of H. pylori based on rates of ch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for judging eradication of H. pylori based on rates of ch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for judging eradication of H. pylori based on rates of ch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-960342